Angiodynamics (ANGO) Cash from Financing Activities (2010 - 2026)
Angiodynamics (ANGO) posted Cash from Financing Activities of -$108000.0 for Q2 2026, down 117.39% on a QoQ basis from $621000.0 in Q1 2026, and up 98.13% year-over-year from -$54510.1 in Q2 2025.
Angiodynamics (ANGO) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Angiodynamics' Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$108000.0 for Q2 2026.
- Quarterly Cash from Financing Activities rose 98.13% year-over-year to -$108000.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $564000.0 (up 321.18% YoY) and the FY2026 annual result came in at $564000.0, up 321.18% from the prior year.
- Cash from Financing Activities was -$108000.0 for Q2 2026 at Angiodynamics, down from $621000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $24.4 million in Q3 2022 and bottomed at -$59.6 million in Q3 2023.
- A 5-year average of -$2.2 million and a median of $103000.0 in 2022 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities sank 441.75% — and 2025, when it surged 929.83%.
- Angiodynamics' Cash from Financing Activities stood at $103000.0 in 2022, then sank by 441.75% to -$352000.0 in 2023, then tumbled by 219.03% to -$1.1 million in 2024, then jumped by 91.81% to -$92000.0 in 2025, then dropped by 17.39% to -$108000.0 in 2026.
- Business Quant data shows ANGO's Cash from Financing Activities at -$108000.0 in Q2 2026, $621000.0 in Q1 2026, and -$92000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Angiodynamics | 558.11 Mn | 504.25 Mn | 46.77 Mn | -108,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -108,000.00 |
| May 31, 2026 | -108,000.00 |
| Feb 28, 2026 | 621,000.00 |
| Feb 28, 2026 | 621,000.00 |
| Nov 30, 2025 | -92,000.00 |
| Nov 30, 2025 | -92,000.00 |
| Aug 31, 2025 | 143,000.00 |
| Aug 31, 2025 | 143,000.00 |
| May 31, 2025 | -5.77 Mn |
| May 31, 2025 | -5.77 Mn |
| Feb 28, 2025 | 7.15 Mn |
| Feb 28, 2025 | 7.15 Mn |
| Nov 30, 2024 | -1.12 Mn |
| Nov 30, 2024 | -1.12 Mn |
| Aug 31, 2024 | -509,000.00 |
| Aug 31, 2024 | -509,000.00 |
| May 31, 2024 | -5.00 Mn |
| May 31, 2024 | -5.00 Mn |
| Feb 29, 2024 | 694,000.00 |
| Feb 29, 2024 | 694,000.00 |